KBIO LABS Inc. (KOSDAQ:038530)
South Korea flag South Korea · Delayed Price · Currency is KRW
961.00
-34.00 (-3.42%)
At close: Aug 21, 2026

KBIO LABS Revenue

KBIO LABS had revenue of 15.87B KRW in the quarter ending March 31, 2026, a decrease of -22.75%. This brings the company's revenue in the last twelve months to 82.64B, up 2.01% year-over-year. In the year 2025, KBIO LABS had annual revenue of 87.31B with 14.11% growth.

Revenue (ttm)
82.64B
Revenue Growth
+2.01%
P/S Ratio
0.30
Revenue / Employee
2.17B
Employees
38
Market Cap
24.84B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202587.31B10.80B14.11%
Dec 31, 202476.51B49.19B180.02%
Dec 31, 202327.32B-3.80B-12.22%
Dec 31, 202231.13B22.41B256.90%
Dec 31, 20218.72B3.01B52.80%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Dec 31, 2013 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
CammSys502.22B
Photon139.52B
Signetics104.52B
PIMS Inc.62.97B
CNPLUS60.13B
Seoul Electronics & Telecom30.85B
NWC Co.,Ltd.26.25B
Dongil Technology,23.12B
Revenue Rankings